Open-Label Extension Study of Rufinamide Given as Adjunctive Therapy in Patients With Refractory Partial Seizures
Status:
Terminated
Trial end date:
2010-05-14
Target enrollment:
Participant gender:
Summary
This was an open-label extension study in adolescent and adult (between 12 and 80 years old)
participants who had completed their participation in Study E2080-A001-301. The main
objective of this study was to evaluate the safety and efficacy of long-term administration
of rufinamide for the control of epileptic seizures in participants who had refractory
partial seizures despite treatment with a maximum of three approved antiepileptic drugs
(AEDs).